Rwanda will start vaccination trials to combat the deadly Marburg virus
Nidhi Tiwari October 04, 2024 03:27 PM

In the next few days, Rwanda is getting ready to start vaccination and treatment trials for the Marburg virus sickness.

Since the epidemic started last month, 36 confirmed cases and 11 deaths have been recorded nationwide. Health experts stated on Thursday that there are no authorized therapies or vaccinations for this illness at this time.

“About to begin therapeutic and vaccination clinical studies to safeguard high-risk populations. In a post on X, Rwandan Minister of State for Health Yvan Butera said, “Let’s collaborate to contain this.”

According to Xinhua news agency, Brian Chilombo, the Country Representative of the World Health Organization (WHO) for Rwanda, this program is a part of a larger effort that was started two years ago and involves 17 African countries that are eager to engage in clinical trials.

In a Wednesday television interview, Chilombo said that Rwanda is assisting the WHO in preparing its scientists. “A few medications and vaccines show potential but have not yet received approval. We will therefore be bringing in some of those medications and vaccinations over the course of the next several days, collaborating with producers, other nations, donors, and the government. We are hoping to develop some treatments and vaccinations that will be useful for Marburg,” he said.

Rwandan health authorities are closely monitoring 410 contacts of confirmed patients as part of their reaction to stop the spread of the disease.

In addition, actions have been taken to limit meetings associated with the Marburg fatalities and outlaw the visitingation of hospitalized patients.

Additionally, the health ministry has advised anybody exhibiting symptoms including a high temperature, excruciating headaches, or vomiting to get medical help as soon as possible.

 

© Copyright @2024 LIDEA. All Rights Reserved.